HK Stock MarketDetailed Quotes

02367 GIANT BIOGENE

Watchlist
  • 80.500
  • +0.500+0.63%
Market Closed May 2 16:08 CST
86.21BMarket Cap38.70P/E (TTM)

GIANT BIOGENE Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(FY)Dec 31, 2021
(FY)Dec 31, 2020
(FY)Dec 31, 2019
Turnover
57.17%5.54B
58.21%2.54B
49.05%3.52B
--1.61B
52.30%2.36B
30.41%1.55B
24.44%1.19B
--956.7M
Operating income
57.17%5.54B
58.21%2.54B
49.05%3.52B
1.61B
52.30%2.36B
30.41%1.55B
24.44%1.19B
956.7M
Cost of sales
-71.90%-991.9M
-75.57%-447.19M
-56.28%-577.01M
---254.7M
-86.33%-369.21M
-8.04%-198.15M
-14.64%-183.41M
---159.99M
Operating expenses
-71.90%-991.9M
-75.57%-447.19M
-56.28%-577.01M
-254.7M
-86.33%-369.21M
-8.04%-198.15M
-14.64%-183.41M
-159.99M
Gross profit
54.28%4.55B
54.94%2.09B
47.71%2.95B
1.35B
47.32%2B
34.48%1.35B
26.40%1.01B
796.71M
Selling expenses
-72.46%-2.01B
-60.67%-892.02M
-64.86%-1.16B
---555.18M
-104.03%-706.37M
-118.54%-346.21M
-68.91%-158.42M
---93.79M
Administrative expenses
-55.74%-150.54M
-38.26%-65.65M
12.98%-96.66M
---47.48M
-53.68%-111.07M
-119.07%-72.27M
-14.38%-32.99M
---28.85M
Research and development expenses
-42.06%-106.5M
-43.20%-48.7M
-70.22%-74.97M
---34.01M
-76.50%-44.04M
-86.49%-24.95M
-17.38%-13.38M
---11.4M
Impairment and provision
-113.14%-92K
-247.59%-490K
214.01%700K
--332K
-88.34%-614K
-113.15%-326K
342.09%2.48M
---1.02M
-Other impairment is provision
-113.14%-92K
-247.59%-490K
214.01%700K
--332K
-88.34%-614K
-113.15%-326K
342.09%2.48M
---1.02M
Special items of operating profit
32.18%176.45M
12.93%68.87M
199.11%133.49M
--60.98M
-28.41%44.63M
-63.00%62.35M
998.29%168.49M
--15.34M
Operating profit
40.84%2.46B
48.94%1.16B
48.18%1.75B
775.64M
21.06%1.18B
-0.03%972.92M
43.76%973.24M
677M
Financing cost
-113.39%-239K
5.26%-54K
-433.33%-112K
---57K
---21K
----
----
----
Earning before tax
40.84%2.46B
48.94%1.16B
48.17%1.75B
775.58M
21.05%1.18B
-0.03%972.92M
43.76%973.24M
677M
Tax
-33.39%-396.03M
-59.40%-174.64M
-68.53%-296.89M
---109.56M
-21.67%-176.16M
1.34%-144.79M
-44.14%-146.76M
---101.82M
After-tax profit from continuing operations
42.36%2.06B
47.22%980.55M
44.59%1.45B
666.02M
20.95%1B
0.20%828.13M
43.69%826.49M
575.18M
Earning after tax
42.36%2.06B
47.22%980.55M
44.59%1.45B
666.02M
20.95%1B
0.20%828.13M
43.69%826.49M
575.18M
Minority profit
82.54%-620K
-185.06%-2.61M
-708.88%-3.55M
---917K
---439K
----
-99.85%35K
--22.92M
Profit attributable to shareholders
42.06%2.06B
47.41%983.16M
44.88%1.45B
666.94M
21.00%1B
0.20%828.13M
49.65%826.45M
552.26M
Basic earnings per share
40.94%2.1
47.76%0.99
50.51%1.49
0.67
19.28%0.99
0.00%0.83
50.91%0.83
0.55
Diluted earnings per share
39.19%2.06
46.97%0.97
51.02%1.48
0.66
18.07%0.98
0.00%0.83
50.91%0.83
0.55
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
--
--
Unqualified Opinion
--
Unqualified Opinion
Unqualified Opinion
Unqualified Opinion
Unqualified Opinion
Auditor
--
--
Ernst & Young
--
Ernst & Young
Ernst & Young
Ernst & Young
Ernst & Young
(FY)Dec 31, 2024(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(FY)Dec 31, 2021(FY)Dec 31, 2020(FY)Dec 31, 2019
Turnover 57.17%5.54B58.21%2.54B49.05%3.52B--1.61B52.30%2.36B30.41%1.55B24.44%1.19B--956.7M
Operating income 57.17%5.54B58.21%2.54B49.05%3.52B1.61B52.30%2.36B30.41%1.55B24.44%1.19B956.7M
Cost of sales -71.90%-991.9M-75.57%-447.19M-56.28%-577.01M---254.7M-86.33%-369.21M-8.04%-198.15M-14.64%-183.41M---159.99M
Operating expenses -71.90%-991.9M-75.57%-447.19M-56.28%-577.01M-254.7M-86.33%-369.21M-8.04%-198.15M-14.64%-183.41M-159.99M
Gross profit 54.28%4.55B54.94%2.09B47.71%2.95B1.35B47.32%2B34.48%1.35B26.40%1.01B796.71M
Selling expenses -72.46%-2.01B-60.67%-892.02M-64.86%-1.16B---555.18M-104.03%-706.37M-118.54%-346.21M-68.91%-158.42M---93.79M
Administrative expenses -55.74%-150.54M-38.26%-65.65M12.98%-96.66M---47.48M-53.68%-111.07M-119.07%-72.27M-14.38%-32.99M---28.85M
Research and development expenses -42.06%-106.5M-43.20%-48.7M-70.22%-74.97M---34.01M-76.50%-44.04M-86.49%-24.95M-17.38%-13.38M---11.4M
Impairment and provision -113.14%-92K-247.59%-490K214.01%700K--332K-88.34%-614K-113.15%-326K342.09%2.48M---1.02M
-Other impairment is provision -113.14%-92K-247.59%-490K214.01%700K--332K-88.34%-614K-113.15%-326K342.09%2.48M---1.02M
Special items of operating profit 32.18%176.45M12.93%68.87M199.11%133.49M--60.98M-28.41%44.63M-63.00%62.35M998.29%168.49M--15.34M
Operating profit 40.84%2.46B48.94%1.16B48.18%1.75B775.64M21.06%1.18B-0.03%972.92M43.76%973.24M677M
Financing cost -113.39%-239K5.26%-54K-433.33%-112K---57K---21K------------
Earning before tax 40.84%2.46B48.94%1.16B48.17%1.75B775.58M21.05%1.18B-0.03%972.92M43.76%973.24M677M
Tax -33.39%-396.03M-59.40%-174.64M-68.53%-296.89M---109.56M-21.67%-176.16M1.34%-144.79M-44.14%-146.76M---101.82M
After-tax profit from continuing operations 42.36%2.06B47.22%980.55M44.59%1.45B666.02M20.95%1B0.20%828.13M43.69%826.49M575.18M
Earning after tax 42.36%2.06B47.22%980.55M44.59%1.45B666.02M20.95%1B0.20%828.13M43.69%826.49M575.18M
Minority profit 82.54%-620K-185.06%-2.61M-708.88%-3.55M---917K---439K-----99.85%35K--22.92M
Profit attributable to shareholders 42.06%2.06B47.41%983.16M44.88%1.45B666.94M21.00%1B0.20%828.13M49.65%826.45M552.26M
Basic earnings per share 40.94%2.147.76%0.9950.51%1.490.6719.28%0.990.00%0.8350.91%0.830.55
Diluted earnings per share 39.19%2.0646.97%0.9751.02%1.480.6618.07%0.980.00%0.8350.91%0.830.55
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards IASIASIASIASIASIASIASIAS
Audit Opinions ----Unqualified Opinion--Unqualified OpinionUnqualified OpinionUnqualified OpinionUnqualified Opinion
Auditor ----Ernst & Young--Ernst & YoungErnst & YoungErnst & YoungErnst & Young

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights

Warren Buffett Portfolio Warren Buffett Portfolio

Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.

No. Symbol 5D % Chg
Sample Name
Sample Code
 +6.92%
Sample Name
Sample Code
 +6.65%
Sample Name
Sample Code
 +6.30%
4
Moody's
MCO
+5.96%
5
Jefferies Financial
JEF
+5.28%
Unlock Now

Discussing

Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve Show More
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts

Investment Course

How to Buy Stocks for Beginners
Learn stock market basics and confidently start investing with our beginner-friendly guide to buying stocks. Start your investment journey today!
What Is Options Trading and How to Trade Options
Options trading is carried out by all kinds of investors within individual investment portfolios. Learn how you can put options to work within your own portfolio.
What To Know About Margin Accounts
Discover the essentials of margin accounts, including their benefits, risks, and how to use them effectively in your trading strategy.
Cash Accounts - Covering the Basics
Discover the essentials of cash accounts. Learn what cash accounts are, how they function, their potential benefits, and the differences between cash and margin accounts.
Understanding Fractional Shares: A Beginner's Guide
Discover the basics of fractional shares, how they work, and the process for buying and selling them.

- No more -